NCT05729880

Brief Summary

This study aims to see if ultrasound can be used as a reliable and valid method to measure fatty infiltration, muscle thickness and muscle architecture to provide a quick, cheap and mobile alternative measure of muscle quality to MRI. The MRS and MRI images will be used to validate the ultrasound images.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 16, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 15, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

January 16, 2023

Last Update Submit

May 8, 2024

Conditions

Keywords

ultrasoundmri

Outcome Measures

Primary Outcomes (3)

  • Ultrasound muscle thickness (cm)

    A single ultrasound image can measure both thickness (cm) and echogenecity (AU). Echogenecity has been used as a proxy for fat infiltration. By combining both thickness and fat infiltration and index of muscle quality can be determined

    1 year

  • Ultrasound echogenecity (arbitrary units on histogram)

    A single ultrasound image can measure both thickness (cm) and echogenecity (AU). Echogenecity has been used as a proxy for fat infiltration. By combining both thickness and fat infiltration and index of muscle quality can be determined

    1 year

  • Fat fraction

    Obtained from MRI and will be used to validate the ultrasound echogenecity

    1 year

Study Arms (2)

Older

16 older (\>50y) will be recruited. MRI, MRS and Ultrasound will be measured in each participant in calf and thigh muscle, at the same location within a 1 hour time frame.

Diagnostic Test: MRI, MRSDiagnostic Test: Ultrasound

Young

16 young (\<40y) will be recruited. MRI, MRS and Ultrasound will be measured in each participant in calf and thigh muscle, at the same location within a 1 hour time frame.

Diagnostic Test: MRI, MRSDiagnostic Test: Ultrasound

Interventions

MRI, MRSDIAGNOSTIC_TEST

Scan of right calf and thigh

OlderYoung
UltrasoundDIAGNOSTIC_TEST

Scan of right calf and thigh

OlderYoung

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

General population

You may qualify if:

  • \- Age \<40y or \>50yrs

You may not qualify if:

  • Significant cognitive deficits and the inability to follow directions during assessment.
  • Neurological, neuromuscular, or musculoskeletal disorders that could impair the quality of the muscle. eg. CP, muscular dystrophy or SCI
  • Prosthesis with metalwork, eg. metal work from surgery
  • Aneurysm clip in situ
  • No metal work anywhere, history of metal fragments in eyes, spinal cord or brain.
  • Previous exposure to metal flakes and metallic injury.
  • No external implants; cochlear implant, spinal cord simulator, pacemaker or other implanted electronic devices.
  • Non-removal hearing aids
  • FEMALE ONLY Not pregnant
  • Not claustrophobic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University

Exeter, Devon, EX2 4TH, United Kingdom

Location

MeSH Terms

Conditions

Muscular Atrophy

Interventions

Magnetic Resonance ImagingPositron-Emission TomographyUltrasonography

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomography, Emission-ComputedImage Interpretation, Computer-AssistedImage EnhancementPhotographyRadionuclide ImagingDiagnostic Techniques, Radioisotope

Study Officials

  • Francis Stephens

    University of Exeter

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2023

First Posted

February 15, 2023

Study Start

June 10, 2022

Primary Completion

November 16, 2022

Study Completion

April 1, 2023

Last Updated

May 9, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Participant data will not be shared.

Locations